Back to top

Sanofi: (NYSE: SNY)

(U.S: NYSE) As of Apr 17, 2014 04:01 PM ET

 Add to portfolio

 ZacksTrade Now

$52.34 USD

+0.67 (1.30%)

Volume: 856,071

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.

General Information

SANOFI-AVENTIS

54 RUE LA BOETIE

PARIS, I0 75008

Phone: 33-1-53-77-44-00

Fax: 33-1-53-77-43-03

Web: http://www.sanofi-aventis.com

Email: NA

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2014
Next EPS Date 5/1/2014

EPS Information

Current Quarter EPS Consensus Estimate 0.84
Current Year EPS Consensus Estimate 3.57
Estimated Long-Term EPS Growth Rate 7.70
Next EPS Report Date 5/1/2014

Price and Volume Information

Zacks Rank
Yesterday's Close 51.67
52 Week High 55.94
52 Week Low 46.95
Beta 1.05
20 Day Moving Average 1,884,003.63
Target Price Consensus 57.04

SNY

% Price Change
4 Week 2.40
12 Week 0.27
YTD -3.90
% Price Change Relative to S&P 500
4 Week 2.31
12 Week -0.67
YTD -3.62
Share Information
Shares Outstanding (millions) 2,648.64
Market Capitalization (millions) 136,855.22
Short Ratio 2.72
Last Split Date NA
Dividend Information
Dividend Yield 2.43%
Annual Dividend $1.25
Payout Ratio 0.37
Change in Payout Ratio NA
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 14.48
Trailing 12 Months 15.24
PEG Ratio 1.88
EPS Growth
vs. Previous Year 19.23%
vs. Previous Quarter 0.00%
   
Sales Growth
vs. Previous Year -0.98%
vs. Previous Quarter -1.30%
   
Price Ratios
Price/Book 1.81
Price/Cash Flow 8.32
Price / Sales 3.09
ROE
3/31/14 NA
12/31/13 12.05
9/30/13 11.69
ROA
3/31/14 NA
12/31/13 7.07
9/30/13 6.73
Current Ratio
3/31/14 NA
12/31/13 1.71
9/30/13 NA
Quick Ratio
3/31/14 NA
12/31/13 1.26
9/30/13 NA
Operating Margin
3/31/14 NA
12/31/13 20.31
9/30/13 19.41
Net Margin
3/31/14 NA
12/31/13 11.31
9/30/13 9.32
Pre-Tax Margin
3/31/14 NA
12/31/13 13.82
9/30/13 10.83
Book Value
3/31/14 NA
12/31/13 28.43
9/30/13 NA
Inventory Turnover
3/31/14 NA
12/31/13 1.68
9/30/13 1.68
Debt-to-Equity
3/31/14 NA
12/31/13 0.18
9/30/13 NA
Debt to Capital
3/31/14 NA
12/31/13 15.44
9/30/13 NA